Nano-X Imaging is facing a proposed securities class action in New Jersey federal court over statements about its business operations and manufacturing scale-up.
The complaint was filed June 12 in the U.S. District Court for the District of New Jersey by plaintiff Katlyn Steele. Named defendants include Nano-X Imaging, CEO Erez Meltzer, and CFO Ran Daniel.
The proposed class covers investors who purchased or acquired Nano-X securities between March 31, 2025, and April 17, 2026. The lawsuit seeks damages under Sections 10(b) and 20(a) of the Securities Exchange Act and Rule 10b-5.
According to Pomerantz LLP, the complaint alleges Nano-X overstated efficiency gains and demand for its products. It also alleges the company’s production and manufacturing operations were poorly aligned with demand.
Financial results disclosed after the class period are central to the claim. On April 20, Nano-X reported a fourth-quarter 2025 net loss of $33.4M, including a $17.5M impairment charge related to a restructuring initiative at its Korean chip manufacturing facility.
Nano-X said the restructuring was tied to a shift toward “a more efficient outsourced production model” aligned with current and anticipated demand.
The April 20 announcement also said CFO Ran Daniel would step down effective July 31, 2026. Nano-X named Guy Nathanzon as incoming CFO, with an expected start date of July 14.
Earlier securities litigation also appears in Nano-X’s public filings. A 2023 SEC filing states that Nano-X entered a formal agreement on June 2, 2023, to settle prior shareholder class action litigation for $8M, subject to court approval and other conditions.
The new lawsuit remains pending. The allegations have not been adjudicated.
Company:Nano-X Imaging
Sources
- STEELE v. NANO-X IMAGING LTD. et al. Government document
- Form 6-K Nano-X Imaging Ltd.. Regulatory filing
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
